Elite's Monster Unique second generation IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone. It can also be used with CNS stimulants to make them abuse deterrent. The holy grail of IR ADFs trials resume in 2022 Making others obsolete.
Hammer locking the IR ADF market in 2022
Patent Pending
Quote Nasrat:
“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
